ArticleOphthalmology2025
Accelerated Epigenetic Aging Is Associated with Faster Glaucoma Progression: A DNA Methylation Study.
Article in Ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The Molecular Basis of Ocular Aging: Mechanisms, Pathologies, and Emerging Therapeutics.Investigative ophthalmology & visual science · 2026Review
- Transcending genome-wide association studies to create useful multi-omic views of glaucoma.Progress in retinal and eye research · 2026Review
- Proteomic clocks combined with deep learning phenotypes track eye aging and diseases.NPJ digital medicine · 2026Article
- Visual field progression in varying severities of treated patients with primary angle closure glaucoma.Scientific reports · 2026Article
- Sensory impairments and epigenetic aging: insights from self-rated hearing and vision in United States adults.GeroScience · 2026Article
- Emerging role of epigenetic mechanisms in glaucoma and their translational potential.Frontiers in genetics · 2026Review
- Epigenetics of glaucoma in the trabecular meshwork.Clinical epigenetics · 2025Review
- Article
- Accelerated Biological Aging and Genetic Pleiotropy in Age-Related Eye Diseases: A Population-Based Cohort and Integrative Genetic Analysis.Investigative ophthalmology & visual science · 2025Article
- Potential Functions and Causal Associations of GNLY in Primary Open-Angle Glaucoma: Integration of Blood-Derived Proteome, Transcriptome, and Experimental Verification.Journal of inflammation research · 2025Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
purposeTo investigate the association between epigenetic age acceleration and glaucoma progression.
designRetrospective cohort study.
participantsA total of 100 patients with primary open-angle glaucoma (POAG) with fast progression and 100 patients with POAG with slow progression.
methodsPatients were classified as fast or slow progressors based on rates of change in standard automated perimetry (SAP) mean deviation (MD) and retinal nerve fiber layer (RNFL) thickness. Epigenetic age was calculated using the Horvath, Hannum, PhenoAge, and GrimAge clocks from DNA methylation profiles obtained from blood samples. Age acceleration was defined as the residual from a linear regression of epigenetic age on chronologic age, with positive values suggesting faster biological aging. Multivariable logistic regression models estimated the association between age acceleration and likelihood of fast progression, adjusting for confounders.
main outcome measuresDifference in epigenetic age acceleration between fast and slow glaucoma progressors.
resultsThe mean rate of SAP MD change in the fastest progressing eye was -1.06 dB/year (95% confidence interval [CI], -1.28 to -0.85 dB/year) for fast progressors compared with -0.10 dB/year (95% CI, -0.16 to -0.04 dB/year) for slow progressors (P < 0.001). For RNFL thickness, corresponding values were -1.60 μm/year (95% CI, -1.97 to -1.23 μm/year) and -0.76 μm/year (95% CI, -1.04 to -0.48 μm/year), respectively (P < 0.001). Fast progressors demonstrated significantly greater age acceleration compared with slow progressors for the Horvath clock (mean difference, 2.93 years; 95% CI, 1.48-4.39 years; P < 0.001) and Hannum clock (mean difference, 1.24 years; 95% CI, 0.03-2.46 years; P = 0.045). In multivariable models, each year of Horvath age acceleration was associated with 15% higher odds of fast progression (odds ratio, 1.15; 95% CI, 1.07-1.23; P < 0.001). Hannum and GrimAge clocks also showed significant associations with fast progression. The association between age acceleration and fast progression was stronger in those with relatively low IOP during follow-up.
conclusionsAccelerated epigenetic aging was associated with faster glaucoma progression. These findings suggest that faster biological age, as reflected in DNA methylation, may increase optic nerve susceptibility to damage, highlighting epigenetic age as a potential prognostic biomarker. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.